Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Study Site, New York

Study Site, New York

Study Site, New York

Study Site, Staten Island

Study Site, Albany

Study Site, Johnson City

Study Site, Rochester

Study Site, Hershey

Study Site, Allentown

Study Site, Philadelphia

Study Site, Philadelphia

Study Site, West Reading

Study Site, Newark

Study Site, Baltimore

Study Site, Baltimore

Study Site, Charlottesville

Study Site, Richmond

Study Site, Durham

Study Site, Orlando

Study Site, Tampa

Study Site, Jackson

Study Site, Hazard

Study Site, Royal Oak

Study Site, Ann Arbor

Study Site, Minneapolis

Study Site, Duluth

Study Site, Oak Park

Study Site, Chicago

Study Site, St Louis

Study Site, Temple

Study Site 2, Houston

Study Site, Houston

Study Site, Austin

Study Site, El Paso

Study Site, Salt Lake City

Study Site, Albuquerque

Study Site, Los Angeles

Study Site, San Franciso

Study Site, Kemerovo

Study Site, Birmingham

Study Site, Boston

Study Site, Worchester

Study Site 1, Minsk

Study Site 2, Minsk

Study Site, Pleven

Study Site, Plovdiv

Study Site, Rousse

Study Site 1, Sofia

Study Site 2, Sofia

Study Site 3, Sofia

Study Site 4, Sofia

Study Site, Brasov

Study Site 1, Bucharest

Study Site 2, Bucharest

Study Site 3, Bucharest

Study Site, Cluj-Napoca

Study Site, Timișoara

Study Site, Arkhangelsk

Study Site 1, Barnaul

Study Site 2, Barnaul

Study Site, Kazan'

Study Site 1, Moscow

Study Site 2, Moscow

Study Site 1, Nizhny Novgorod

Study Site 2, Nizhny Novgorod

Study Site 1, Saint Petersburg

Study Site 2, Saint Petersburg

Study Site, Kharkiv

Study Site, Vinnytsa